[Treatment of New Daily Persistent Headache With Esketamine: Report of One Case].
Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae – August 01, 2024
Source: PubMed
Summary
A breakthrough in treating severe chronic headaches shows promise with esketamine therapy. When conventional treatments failed, doctors successfully used low-dose esketamine to help a patient with new daily persistent headache - a rare but debilitating condition with sudden onset. The treatment provided significant pain relief where other approaches, including deep brain stimulation, had fallen short.
Abstract
New daily persistent headache (NDPH) is a kind of persistent headache that patients can identify the exact date of the sudden onset.It is one of the rare primary headaches difficult to be cured and may lead to disability,seriously affecting the daily life and work.The exact pathogenesis of NDPH remains unclear,which makes the treatment difficult.Here we report a case of refractory NDPH treated by intravenous injection of esketamine at a sub-anesthetic dose.